Frontiers in Oncology (Feb 2022)
Corrigendum: DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression
- Li-Bao Gong,
- Li-Bao Gong,
- Ti Wen,
- Ti Wen,
- Zhi Li,
- Zhi Li,
- Xing Xin,
- Xing Xin,
- Xiao-Fang Che,
- Xiao-Fang Che,
- Jin Wang,
- Jin Wang,
- Yun-Peng Liu,
- Yun-Peng Liu,
- Xiu-Juan Qu,
- Xiu-Juan Qu
Affiliations
- Li-Bao Gong
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China
- Li-Bao Gong
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China
- Ti Wen
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China
- Ti Wen
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China
- Zhi Li
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China
- Zhi Li
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China
- Xing Xin
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China
- Xing Xin
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China
- Xiao-Fang Che
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China
- Xiao-Fang Che
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China
- Jin Wang
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China
- Jin Wang
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China
- Yun-Peng Liu
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China
- Yun-Peng Liu
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China
- Xiu-Juan Qu
- Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China
- Xiu-Juan Qu
- Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, China
- DOI
- https://doi.org/10.3389/fonc.2022.819244
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords
